Improving Human Health Through Innovation
ApoPharma Inc. is an innovative drug company devoted to providing drug products that help improve the quality of life of patients with debilitating and life-threatening diseases.

Our Strength is in Our Size
Our focus is on the discovery and development of new molecules in 2 key areas with the goal of providing much needed treatment options where none currently exist.

1) Haematological conditions where iron plays a role;
2) Neurodegenerative diseases; and,

Driving Innovation
Investigation into the role of iron in human diseases and how to use iron chelators to treat conditions created or worsened by iron is a major research area of ApoPharma’s.  Our research includes conditions with generalized iron overload such as in patients who have repeated blood transfusions, as well as conditions where there is no generalized iron overload, only localized regions of slightly elevated iron or even intracellular mishandling of iron, leading to iron-induced pathology, including certain neurological disorders, such as Friedreich Ataxia, Pantothenate Kinase Associated Neurodegeneration (PKAN) and Parkinson’s Disease.

Please visit our exhibition booth



Visit our website at www.apopharma.com